Christopher F. Carpenter, MD

Oakland University William Beaumont School of Medicine

Disclosure(s): AstraZeneca: Grant/Research Support; Cidara Therapeutics: Advisor/Consultant; Dompe Farmaceutici: Grant/Research Support; F2G LTD: Advisor/Consultant; Rebiotix: Advisor/Consultant

Poster(s):

• (P-215) Screening to Prophylax against Clostridioides difficile Infection: A Trial of Primary Prophylaxis in C. difficile Carriers
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT